Filing Flows › DarioHealth (DRIO) › Q2 2026 › vs Q2 2025
DarioHealth (DRIO) Q2 2026 vs Q2 2025 (year over year)
DarioHealth's revenue fell $192K (-4%) from $5.4M in Q2 2025 to $5.2M in Q2 2026. The biggest changes: Services −$1.1M (-29%); Hardware and Consumable Products +$884K (+52%).
DarioHealth, Q2 2026: revenue $5.2M (-4% year over year), operating margin -125.1%, net loss $7.9M, operating cash flow −$6.1M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Hardware and Consumable Products | $2.6M | $1.7M | $884K | +52% |
| Services | $2.6M | $3.7M | −$1.1M | -29% |
| Revenue | $5.2M | $5.4M | −$192K | -4% |
| Net loss | $7.9M | $13.0M | −$5.1M | -39% |
| Costs & expenses | $13.1M | $18.4M | −$5.3M | -29% |
| Operating costs | $11.7M | $14.6M | −$2.9M | -20% |
| Interest & other, net | $1.1M | $3.8M | −$2.7M | -71% |
| Income tax | $328K | $0 | $328K | — |
| Cost of revenue | $2.0M | $2.4M | −$420K | -17% |
| Research & development | $2.1M | $3.7M | −$1.6M | -44% |
| Sales & marketing | $5.0M | $5.2M | −$260K | -5% |
| General & admin | $2.6M | $3.2M | −$612K | -19% |
| Operating cash sources | $7.9M | $13.0M | −$5.1M | -39% |
| Depreciation & amortization | $515K | $802K | −$287K | -36% |
| Share-based compensation | $632K | $2.0M | −$1.4M | -69% |
| Working capital & other | $694K | $4.1M | −$3.4M | -83% |
| Cash used in operations | $6.1M | $6.0M | $52K | +0.9% |
| Net loss absorbed | $7.9M | $13.0M | −$5.1M | -39% |
Questions
How much did DarioHealth's revenue grow year over year in Q2 2026?
DarioHealth's revenue fell $192K (-4%) from $5.4M in Q2 2025 to $5.2M in Q2 2026.
What drove DarioHealth's revenue change in Q2 2026?
Services −$1.1M (-29%); Hardware and Consumable Products +$884K (+52%).